NanoViricides' nanotech drug delivery platform has the potential to eliminate viruses, the firm says as construction began on a manufacturing facility to support upcoming clinical trials.
Tamiflu suppresses the virus while broad-spectrum FluCide will eliminate/destroy the virus strains.
The company also believes that by moving away from a vaccine-type approach, treatment can also become far more cost efficient. In an extended trial, FluCide was shown to be 1,500 times more effective than TamiFlu in a lethal animal model.
To support the upcoming trials, construction of the 18,000 sq. ft. facility is expected to be completed by mid 2014. The plant was previously a printing plant and according to Dr. Seymour, "needed a complete renovation to make it a sterile pilot manufacturing facility."
And with the advent of 3D printing of human tissue and organs, who is to say that within the next five years, the new Pilot manufacturing Plant will not house a nanoviricides 3D printer? Possible? Just speculating!
The "bio-ink cartridges" for this 3D nanoviricide-printer???